Tirofiban After Successful MT Recanalization in AIS
NCT06265051 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1380
Last updated 2026-03-11
Summary
Acute ischemic stroke with large vessel occlusion is a frequently occurring life-threatening condition. Although endovascular treatment can effectively open occluded vessels, the successful reperfusion rate exceeds 80%, but the rate of good prognosis is less than 50%. The current clinical focus is on how to improve futile recanalization. Tirofiban is widely used in the treatment of stroke, as it can effectively prevent vascular reocclusion and improve microcirculation perfusion. It has the potential to improve futile recanalization, but there is a lack of high-level evidence-based medical support. This multicenter, prospective, double-blind, randomized controlled trial was conducted to assess the effectiveness and safety of sequential tirofiban therapy following successful mechanical thrombectomy within 24 hours of onset.
Conditions
- Acute Ischemic Stroke
- Vessel Occlusion
Interventions
- DRUG
-
Tirofiban
After the completion of endovascular treatment and successful recanalization (mTICI 2b/3), the patients were randomly assigned to the experimental group. Tirofiban 5μg/kg was administered intravenously through the catheter artery at a rate of 1ml/min, followed by an intravenous infusion of 0.1μg/(kg·min) for 24 hours. Standard medical treatment was administered after the surgery.
- DRUG
-
Saline placebo
After the completion of endovascular treatment and successful recanalization (mTICI 2b/3), the patients were randomly assigned to the experimental group. Saline placebo was administered in the same manner as tirofiban group. Standard medical treatment was administered after the surgery.
Sponsors & Collaborators
-
Fujian Medical University Union Hospital
collaborator OTHER -
Jingzhou Hospital Affiliated to Yangtze University
collaborator UNKNOWN -
Xiangyang No 1 People's Hospital Affiliated to Hubei University of Medicine
collaborator UNKNOWN -
Puren Hospital Affiliated to Wuhan University of Science and Technology
collaborator OTHER -
Zhongnan Hospital
collaborator OTHER -
First Affiliated Hospital of Fujian Medical University
collaborator OTHER -
Huazhong University of Science and Technology Tongji Medical College Affiliated Wuhan Central Hospital
collaborator UNKNOWN -
Xianning Central Hospital
collaborator OTHER -
Shanxi Provincial People's Hospital
collaborator OTHER_GOV -
The Third People's Hospital of Hubei Province
collaborator OTHER -
Jingmen Central Hospital
collaborator UNKNOWN -
Hubei University of Medicine
collaborator OTHER -
Wuhan No.1 Hospital
collaborator OTHER -
Nanyang Central Hospital
collaborator OTHER -
Yichang Central People's Hospital of China Three Gorges University
collaborator UNKNOWN -
The Central Hospital of Huanggang
collaborator OTHER -
Zoucheng City People's Hospital
collaborator UNKNOWN -
Qujing Central Hospital of Yunnan Province
collaborator UNKNOWN -
Taihe Hospital, Affiliated Hospital of Hubei Province of Medicine
collaborator UNKNOWN -
Second Affiliated Hospital of Soochow University
collaborator OTHER -
The First Affiliated Hospital of Nanchang University
collaborator OTHER -
Central Hospital of Xiaogan
collaborator OTHER -
The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture
collaborator OTHER -
Huangshi Central Hospital
collaborator OTHER -
Zigong No.1 Peoples Hospital
collaborator OTHER -
Xiangyang Hospital of Traditional Chinese Medicine
collaborator UNKNOWN -
The First People's Hospital of Jingzhou City
collaborator UNKNOWN -
The First people's hospital of Xian Yang
collaborator UNKNOWN -
Jiujiang No.1 People's Hospital
collaborator OTHER -
Zhongxiang Hospital of Traditional Chinese Medicine
collaborator UNKNOWN -
Jiangxi Provincial People's Hopital
collaborator OTHER -
The Lichuan ethnic Hospital of Traditional Chinese Medicine
collaborator UNKNOWN -
Xiangyang Central Hospital People's Hospital of Huangpi District
collaborator UNKNOWN -
Quanzhou First Hospital
collaborator OTHER -
Minda Hospital of Hubei Minzu University
collaborator UNKNOWN -
The Cerebrovascular Hospital of Hubei Province
collaborator UNKNOWN -
The First People's Hospital of Changde City
collaborator OTHER -
Longyan First Affiliated Hospital of Fujian Medical University
collaborator UNKNOWN -
Xiangzhou People's Hospital
collaborator UNKNOWN -
Jingmen People's Hospital
collaborator UNKNOWN -
The First People's Hospital of TianMen in Hubei Province
collaborator UNKNOWN -
Hanyang Hospital, Wuhan University of Science & Technology
collaborator UNKNOWN -
Tongcheng People's Hospital
collaborator UNKNOWN -
Gaoyou People's Hospital
collaborator UNKNOWN -
Zaoyang First People's Hospital
collaborator UNKNOWN -
CR & WISCO General Hospital
collaborator UNKNOWN -
Wuhan Hankou Hospital
collaborator UNKNOWN -
Lu'an People's Hospital of Anhui Hospital
collaborator UNKNOWN -
Yingtan People's Hospital
collaborator UNKNOWN -
Shiyan Renmin Hospital
collaborator UNKNOWN -
Dali Bai Autonomous Prefecture People's Hospital
collaborator UNKNOWN -
Three Gorges Hospital of Chongqing University
collaborator OTHER -
The Second People's Hospital of Jingzhou City
collaborator UNKNOWN -
General Hospital of the Yangtze River Shipping
collaborator UNKNOWN -
The Affiliated Hospital Of Southwest Medical University
collaborator OTHER -
Fujian Provincial Hospital
collaborator OTHER -
Zhongxiang People's Hospital
collaborator UNKNOWN -
LiuZhou People's Hospital
collaborator OTHER -
The Fifth Hospital of Wuhan
collaborator OTHER -
Xiaogan First People's Hospital
collaborator UNKNOWN -
Loudi Central Hospital
collaborator OTHER -
Ezhou Central Hospital
collaborator UNKNOWN -
Second Xiangya Hospital of Central South University
collaborator OTHER -
Qingdao Central Hospital
collaborator OTHER -
Taizhou First People's Hospital
collaborator OTHER -
Renmin Hospital of Wuhan University
collaborator OTHER -
Hubei Provincial Hospital of Integrated Chinese & Western Medicine
collaborator UNKNOWN -
The First Affiliated Hospital of Botou Medical College
collaborator UNKNOWN -
Xianfeng People's Hospital
collaborator UNKNOWN -
Wuhan Third Hospital
collaborator OTHER -
The Fourth Hospital of Wuhan
collaborator UNKNOWN -
Chengdu Fifth People's Hospital
collaborator OTHER -
Xingyi People's Hospital
collaborator UNKNOWN -
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
collaborator OTHER -
Shenzhen Hospital of Southern Medical University
collaborator OTHER -
The Third People's Hospital of Jingzhou City
collaborator UNKNOWN -
The First People's Hospital of Jiangxia District
collaborator UNKNOWN -
Xihua People's Hospital
collaborator UNKNOWN -
Shanghai East Hospital
collaborator OTHER -
Xiang Luo
lead OTHER
Principal Investigators
-
Xiang Luo · Tongji Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-09
- Primary Completion
- 2025-12-29
- Completion
- 2025-12-29
Countries
- China
Study Locations
More Related Trials
-
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
NCT07290751 ·Status: RECRUITING ·Phase: PHASE4
-
Tirofiban for Patients Treated With Alteplase
NCT03357133 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke
NCT06045156 ·Status: RECRUITING ·Phase: NA
-
Intravenous Tirofiban After Delayed Thrombolysis in Stroke
NCT07111806 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
NCT05188417 ·Status: UNKNOWN ·Phase: PHASE2
-
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
NCT06319846 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke
NCT04818944 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
NCT05604638 ·Status: RECRUITING ·Phase: PHASE3
-
Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke
NCT05728333 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)
NCT06134622 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban
NCT07135089 ·Status: RECRUITING ·Phase: PHASE3
-
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
NCT04491695 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
NCT07095790 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair
NCT06238115 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
NCT06010628 ·Status: RECRUITING ·Phase: PHASE4
-
Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
NCT03552354 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-II)
NCT05281549 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
NCT05752916 ·Status: COMPLETED ·Phase: PHASE4
-
Argatroban Plus R-tPA for Acute Ischemic Stroke
NCT03740958 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
NCT07205328 ·Status: RECRUITING ·Phase: PHASE2
-
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
NCT06058130 ·Status: RECRUITING ·Phase: NA